ASCO 2024: Bispecific Highlights Infographic

ASCO 2024: Bispecific Highlights

ASCO 2024 showcased 150 bispecific-related abstracts this year, including 139 clinical and 11 preclinical studies, representing a 36% surge from 2023! Our infographic delves into these findings, analysing data by abstract type and trial phase, and presenting the key highlights from the conference.

Download the infographic to discover the top disease indications and leading target combinations that are shaping the current and future bispecific landscape.

ASCO 2024: Bispecific Highlights Infographic

Covered in this Infographic:

Analysis of the 150 bispecific-related abstracts presented at ASCO 2024.
Insights into top disease indications, targets, and target combinations.
Current trends in the bispecific landscape.

To learn more about the infographic and how Beacon Bispecific can enhance your data needs and provide fast insights, please book a research session below or contact us directly on beacon@hansonwade.com.

Download Infographic

You May Also Be Interested In…

Bispecific Landscape Review

Access Review

SITC 2024: Bispecific Post-Conference Report

Access Report

ASCO 2024: Bispecific Highlights

Access Infographic

View All

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more